Manuel Sánchez-Maldonado, Jose
Martínez-Bueno, Manuel
Canhão, Helena
ter Horst, Rob http://orcid.org/0000-0003-0576-5873
Muñoz-Peña, Sonia
Moñiz-Díez, Ana
Rodríguez-Ramos, Ana http://orcid.org/0000-0003-3422-2886
Escudero, Alejandro
Sorensen, Signe B. http://orcid.org/0000-0003-3215-1236
Hetland, Merete L.
Ferrer, Miguel A.
Glintborg, Bente
Filipescu, Ileana
Pérez-Pampin, Eva
Conesa-Zamora, Pablo
García, Antonio
den Broeder, Alfons
De Vita, Salvatore
Hove Jacobsen, Svend Erik
Collantes, Eduardo
Quartuccio, Luca http://orcid.org/0000-0002-0134-6439
Netea, Mihai G. http://orcid.org/0000-0003-2421-6052
Li, Yang
Fonseca, João E.
Jurado, Manuel
López-Nevot, Miguel Ángel
Coenen, Marieke J. H.
Andersen, Vibeke
Cáliz, Rafael
Sainz, Juan http://orcid.org/0000-0002-9355-2423
Article History
Received: 13 May 2019
Accepted: 7 February 2020
First Online: 9 March 2020
Competing interests
: V.A. has received compensation for consultancy and for being a member of an advisory board from MSD (Merck) and Janssen. B.G. received funding for research from AbbVie, Biogen, and Pfizer. M.L.H. received funding for research from Abbvie, Biogen, BMS, CellTrion, MSD, Novartis, Orion, Pfizer, Samsung and UCB. The rest of authors declare that they have no competing interests.